Lonza Group AG Selects Hyderabad for Global Capability Centre, Expanding Presence in India

Lonza Group AG, a world-leading contract development and manufacturing organisation (CDMO), has announced its decision to establish a new Global Capability...

March 09, 2026 | Monday | News
ImmunoScape Advances Seed And Boost Cancer Therapy Programme With United States Clinical Collaboration

The company also announced a strategic investment from Leonardo DiCaprio ImmunoScape Pte. Ltd., an A*STAR spin-out backed by Amgen Ventures an...

March 06, 2026 | Friday | News
MGI Becomes First to Unite Short-Read, Long-Read, and Spatial Omics Under One Platform

MGI Tech Co., Ltd. ("MGI"), a company dedicated to developing core tools and technologies that drive innovation in the life sciences, announced the acqui...

March 05, 2026 | Thursday | News
Acadia Pharmaceuticals Inc. to Seek Re-Examination Following Negative CHMP Opinion on Trofinetide

Acadia Pharmaceuticals Inc. announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) informed the ...

March 04, 2026 | Wednesday | News
Ono and Congruence Deepen Strategic Discovery Alliance Beyond Oncology

Beginning a new drug discovery collaboration using Congruence’s globally recognized Revenir™ platform for the creation of small molecule ...

March 04, 2026 | Wednesday | News
Morcamilast Earns EU Orphan Drug Designation for Rare Inflammatory Skin Disease

Meiji Seika Pharma Co., Ltd. announced that morcamilast (proposed international nonproprietary name; development code: ME3183), a selective phosphodieste...

March 04, 2026 | Wednesday | News
Innovent Biologics, Inc. Announces NMPA Approval of Jaypirca® for CLL/SLL in China

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality...

March 03, 2026 | Tuesday | News
Antengene Corporation Limited Secures South Korea NHIS Reimbursement for XPOVIO® in Multiple Myeloma

- XPOVIO® is the first XPO1 inhibitor approved for reimbursement by South Korea's National Health Insurance Service (NHIS) for the treatment of adult...

March 03, 2026 | Tuesday | News
Biocytogen Secures $5 Million Milestone as IDEAYA Doses First Patient in Phase 1 Trial of Bispecific ADC IDE034

IDE034 is a B7H3/PTK7 bispecific TOP1 ADC designed to target tumor cells expressing both B7H3 and PTK7 preferentially, and is being evaluated as mono...

March 02, 2026 | Monday | News
Fangzhou and Youcare Forge Strategic AI Partnership to Advance Digital Chronic Disease Management in China

Fangzhou Inc. (“Fangzhou” or the “Company”) (HKEX: 06086), a leading provider of AI-driven Internet healthcare solutions, has sig...

March 02, 2026 | Monday | News
Lupin Expands U.S. CNS Portfolio with FDA Approval of Brivaracetam Oral Solution

Global pharma major Lupin Limited (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN)   announced that it has received ap...

February 26, 2026 | Thursday | News
Dr. Reddy’s Advances Biosimilar Pipeline with FDA Review Acceptance for DRL_AB

Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY, along with its subsidiaries together referred to as “D...

February 24, 2026 | Tuesday | News
Hana Health by DSS Imagetech Partners with Overture Life to Introduce Automated Egg-Freezing Technology in India

For the first time in India, couples seeking In Vitro Fertilisation (IVF) treatment for conception can rely on a globally preferred, automated egg-freezi...

February 20, 2026 | Friday | News
Hanyang University ERICA Highlights ER Stress as Therapeutic Target in Global Fatty Liver Epidemic

Endoplasmic reticulum (ER) stress and the unfolded protein response are often implicated in the progression of metabolic dysfunction-associated stea...

February 18, 2026 | Wednesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close